Uganda to benefit from Ushs 440 million GSK funding for research into non-communicable diseases

By Our Reporter Uganda will be one of the 11 African countries to benefit from a research program on Non-Communicable Diseases (NCDs), funded by GlaxoSmithKline (GSK), one of the world’s leading research-based pharmaceutical and healthcare companies GSK announced the third call for proposals as part of the Africa NCD Open Lab this week, strengthening the company’s commitment to much-need